Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility

SAINT-PREX, Switzerland -- Ferring Pharmaceuticals today announced the opening of a state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin® (nadofaragene firadenovec-vncg). This represents a significant milestone in Ferring’s capabilities and capacity to meet the current and expected growth in demand for this gene therapy for people with non-muscle invasive bladder cancer (NMIBC). Read More

Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility

Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility

Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility

Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility
Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Sonar to Improve the Quality of AI-Generated Code, Provide Automated Fix Recommendations
Mullen Subsidiary, Bollinger Motors, Delivers First B4 Trucks and Receives Payment in Full

South Africa Weighs Measures to Ease Electricity Price Increase